FDA Label for Opsin Ii 6015

View Indications, Usage & Precautions

Opsin Ii 6015 Product Label

The following document was submitted to the FDA by the labeler of this product Professional Complementary Health Formulas. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Active Ingredients



Allium cepa 3X
Ambrosia artemisiaefolia 3X
Euphrasia officinalis 3X
Wyethia helenioides 3X
Naphthalinum 4X
Adrenalinum 6X
Arundo mauritanica 6X
Sabadilla 6X
Arsenicum album 12X
Histaminum hydrochloricum 12X
Natrum muriaticum 12X
Tabacum 12X


Questions



Professional Formulas

PO Box 2034 Lake Oswego, OR 97035


Indications



For the temporary relief of runny nose, sneezing, itching of the nose or throat, and itchy or watery eyes due to sensitivity to inhalant allergens.*


Otc - Purpose



*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.


Warnings



In case of overdose, get medical help or contact a poison control center right away.


Otc - Keep Out Of Reach Of Children



Keep out of the reach of children.


Otc - Pregnancy Or Breast Feeding



If pregnant or breastfeeding, ask a healthcare professional before use.


Directions



Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.


Other Information



Tamper resistant. If seal is broken, do not use. After opening, close container tightly and store at room temperature away from heat.


Inactive Ingredients



20% ethanol, purified water.


Label



Est 1985

Professional Formulas

Complementary Health

Opsin II

Homeopathic Remedy

2 FL. OZ. (59 mL)


* Please review the disclaimer below.